Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecular Cancer Therapeutics|May 4, 2018
A Raf-Competitive K-Ras Binder Can Fail to Functionally Antagonize SignalingMonique J Kauke, Alison W Tisdale, Ryan L Kelly, et al.Journal of Molecular Biology|April 29, 2018
Artificial Anti-Tumor Opsonizing Proteins with Fibronectin Scaffolds Engineered for Specificity to Each of the Murine FcγR TypesTiffany F Chen, Kevin K Li, Eric F Zhu, et al.Scientific Reports|July 21, 2017
An engineered protein antagonist of K-Ras/B-Raf interactionMonique J Kauke, Michael W Traxlmayr, Jillian A Parker, et al.Proceedings of the National Academy of Sciences of the United States of America|April 20, 2016
Durable antitumor responses to CD47 blockade require adaptive immune stimulationJonathan T Sockolosky, Michael Dougan, Jessica R Ingram, et al.Nucleic Acids Research|June 24, 2017
Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteinsNicole J Yang, Monique J Kauke, Fangdi Sun, et al.Cell Reports|December 8, 2016
Temporally Programmed CD8α+ DC Activation Enhances Combination Cancer ImmunotherapyAlice Tzeng, Monique J Kauke, Eric F Zhu, et al.The Journal of Experimental Medicine|May 6, 2017
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responsesByron H Kwan, Eric F Zhu, Alice Tzeng, et al.Cancer Cell|April 16, 2015
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2Eric F Zhu, Shuning A Gai, Cary F Opel, et al.Nature Medicine|November 8, 2016
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responsesKelly D Moynihan, Cary F Opel, Gregory L Szeto, et al.Pageof 1